Subject: Improving the reimbursement criteria for medical expenses for cancer and hematology patients requiring high-cost medications, in the case of the use of Erlotinib and Gefitinib in metastatic lung cancer, No. Kor Kor. 0416.2W777, dated 5 November 2025.pdfSubject: Adjustment of food and accommodation rates for domestic training, No. Kor Kor. 0408.4 W 246, dated 31 October 2025.pdf
Subject: Improving the reimbursement criteria for medical expenses for cancer and hematology patients requiring high-cost medications, in the case of the use of Erlotinib and Gefitinib in metastatic lung cancer, No. Kor Kor. 0416.2W777, dated 5 November 2025.pdf
Subject: Adjustment of food and accommodation rates for domestic training, No. Kor Kor. 0408.4 W 246, dated 31 October 2025.pdf
